SUPERNUS PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Supernus Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$21.4M, a 1463% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $12.2M.
  • Supernus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$398M, a 3698% decline from 2022.
  • Supernus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$10.5M, a 92% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$21.4M -$23M -1463% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $1.57M -$78.6M -98% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $80.2M +$102M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 -$22M -$24.3M -1081% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $2.25M +$2.22M +6922% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $32K -$751K -95.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $783K -$367M -99.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 $368M +$367M +60780% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $604K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2015 $147K -$4.85M -97.1% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-06
Q1 2014 $5M +$6.02M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q1 2013 -$1.02M +$36K +3.41% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q1 2012 -$1.06M -$13.7M -108% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $12.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-06-08

SUPERNUS PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.2M +$410M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 -$398M -$387M -3698% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 -$10.5M +$120M +92% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 -$130M -$134M -3765% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $3.56M -$369K -9.39% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $3.93M -$373M -99% Jan 1, 2019 Dec 31, 2019 10-K 2022-04-13
2018 $376M +$371M +6526% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-08
2017 $5.68M +$3.63M +177% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $2.05M +$185K +9.91% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $1.87M -$28.7M -93.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $30.6M -$32.2M -51.3% Jan 1, 2014 Dec 31, 2014 10-K/A 2017-01-20
2013 $62.7M -$25.2M -28.6% Jan 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
2012 $87.9M +$60.8M +225% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $27.1M +$28M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
2010 -$944K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.